Figure 1.

Evaluation of AD-like symptoms induced by treatment of DNCB. (a) Dermatitis score was assessed once a week for 9 weeks following induction of AD. Severity of dermatitis was evaluated as sum of the score for five clinical symptoms. (b) Serum was prepared a day after the last treatment with DNCB for measurement of serum total IgE level. Both the dermatitis score and serum total IgE levels were expressed as mean ± SD (NC group: n = 8, AD group: n = 40). ^### P < 0.001, significantly different from the normal group.